Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

KDM3A leads to the methylation of TP53. 1 / 1

| 1

➶

reach

"Since KDM3A knockdown robustly increased the expression of PUMA in three different breast cancer cell lines and p53 binding sites on the PUMA promoter are well characterized, we first examined how KDM3A modulated p53 binding to the PUMA promoter by demethylating p53."

27270439

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...